Susquehanna International Group, LLP Pharma Cyte Biotech, Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 16, 2023	SELL	$2.83 - $3.03 $69,052 - $73,932	-24,400 Reduced 67.59%	11,700 $34,000
Q4 2022 Feb 14, 2023	BUY	$2.39 - $3.07 $3,346 - $4,298	1,400 Added 4.03%	36,100 $105,000
Q3 2022 Nov 14, 2022	BUY	$2.24 - $2.85 $77,728 - $98,895	34,700 New	34,700 $83,000
Q1 2022 May 16, 2022	BUY	$1.91 - $2.77 $24,639 - $35,733	12,900 Added 42.86%	43,000 $99,000
Q3 2021 Nov 15, 2021	BUY	$2.28 - $16.9 $68,628 - $508,689	30,100 New	30,100 $95,000

1.12M

Ticker PMCB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,750,100
Market Cap $33M
Description
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.